Penis Enlargement Erect and Flaccid Results: Why Both States Matter

Introduction: The Question Every Serious Candidate Asks

Men researching penile enhancement procedures inevitably arrive at the same fundamental question: what will the results actually look like—both in the locker room and in the bedroom? Yet most clinical content addresses only one state or the other, leaving a significant gap in understanding.

This article provides a biomechanically honest explanation of why results differ between flaccid and erect states, and why that difference is not a flaw but a predictable, physiologically explained outcome. According to a 2025 Peking University perception study, contemporary surveys show men are most dissatisfied with flaccid appearance (27%), followed by erect length (19%) and erect girth (15%)—framing flaccid-state results as the primary driver of enhancement decisions.

Understanding penis enlargement erect and flaccid results requires more than marketing claims—it requires knowing the physiology behind each state. For high-income professional men who have long dismissed the possibility of a credible solution, the clinical depth presented here provides the evidence-based analysis necessary to make a confident decision.

Why the Penis Behaves Differently in Each State: The Physiology

The penis exists in two distinct physiological states governed by fundamentally different mechanisms. In the flaccid state, intracavernosal pressure remains low, smooth muscle stays contracted, and blood inflow is minimal. In the erect state, smooth muscle relaxes, the corpora cavernosa engorge with blood, and significant hydraulic pressure develops internally.

This internal pressure during erection is the key to understanding enhancement outcomes. When erect, the corpora cavernosa expand under substantial hydraulic force—this pressure compresses subcutaneous tissue layers, including any filler or graft material placed beneath the penile skin. This compression mechanism is the core biomechanical reason why erect gains are consistently smaller than flaccid gains across all enhancement modalities.

In the flaccid state, no internal hydraulic pressure exists. Subcutaneous volume from filler, graft, or implant expresses itself fully without compression, which is why flaccid gains are always the larger of the two measurements.

For baseline reference, normal average penile dimensions according to a 2024 systematic review of surgical outcomes and quality of life include: flaccid length approximately 9.16 cm, stretched length approximately 13.24 cm, flaccid circumference approximately 9.31 cm, and erect circumference approximately 11.66 cm. Clinical protocol requires measuring flaccid, stretched, and erect dimensions before and after any procedure—stretched penile length (SPL) is the gold standard predictor of erect length, not flaccid length alone.

The Flaccid vs. Erect Gains Gap: What the Clinical Data Shows

The data speaks clearly: a 2022 study published in Translational Andrology and Urology documented HA filler producing flaccid girth increases of approximately 3.41 cm versus erect girth increases of approximately 1.32 cm at peak (one month post-injection). This ratio illustrates the gap with precision.

A 2025 single-center study of 324 patients published in the Journal of Sexual Medicine found a mean flaccid girth increase of 2.5 cm with 89% patient satisfaction and no serious adverse events—reinforcing that flaccid gains are the dominant measurable outcome.

For surgical context, penile traction therapy produces mean increases of 1.7 cm flaccid, 1.3 cm stretched, and 1.2 cm erect length—the only non-surgical method with documented erect length gains. Suspensory ligament release increases flaccid length by 1–3 cm on average by changing the angle of the penis but does not increase true erect length and can destabilize erection angle if not performed with advanced repositioning techniques.

Decellularized dermal matrix grafts (HADM) show a recognized disadvantage: flaccid girth increases significantly more than erect girth. This discrepancy is documented in clinical literature but rarely disclosed in patient-facing content. The flaccid-to-erect gains gap is not a failure of the procedure—it is a predictable physiological outcome that should be communicated transparently in every consultation.

Grower vs. Shower: The Predictive Framework

A clinically significant distinction exists between “growers” and “showers.” Growers are men whose penis expands significantly from flaccid to erect (mean change ≥4 cm), while showers experience minimal flaccid-to-erect change (less than 4 cm).

The landmark 2018 IJIR study by Yafi et al. established that 26% of men are growers and 74% are showers, with younger age as the only significant predictor. This ratio has direct implications for how enhancement results appear in each state.

The grower’s outcome profile: Growers see larger absolute flaccid gains because the flaccid state has more room for volume expression. However, they experience proportionally smaller erect gains relative to total erect size, since dramatic expansion compresses subcutaneous material.

The shower’s outcome profile: Showers experience more consistent results across both states because the flaccid-to-erect transition involves less hydraulic expansion and therefore less compression of enhancement material.

The grower anatomy creates a unique planning challenge: because the penis expands dramatically during erection, excessive filler or poor placement can lead to shifting or asymmetry when erect. Experienced providers recommend staged, conservative treatment for growers.

This framework serves as a tool for personalized outcome planning—not a limitation, but a clinical variable that skilled providers use to customize treatment protocol, staging, and volume for each patient’s anatomy. Stoller Medical Group’s staged treatment philosophy is specifically designed to accommodate anatomical variability, including the grower-shower spectrum, for optimal results in both states.

How Hyaluronic Acid Filler Produces Natural Results in Both States

The mechanism behind HA filler’s performance in the flaccid state relates to its hydrophilic (water-attracting) properties. HA integrates into subcutaneous tissue and resists corpus contraction—this specific biochemical property produces visible flaccid enhancement.

In the erect state, HA gel is viscoelastic and compressible, allowing it to yield to intracavernosal pressure during erection without creating rigidity, unnatural texture, or asymmetry. A December 2025 ultrasound study confirmed that HA filler integrates into subcutaneous tissue without nodularity at one-month follow-up—supporting the natural appearance claim with imaging evidence rather than marketing language.

By comparison, PMMA (polymethylmethacrylate) fillers produce the largest girth increase but the lowest satisfaction improvement among filler types, likely because the harder material gives an unnatural feel—particularly noticeable in the erect state. Fat injection carries a high risk of uneven resorption, leading to irregular contours in both flaccid and erect states.

A meta-analysis of HA and polylactic acid for penile augmentation found that HA filler increases penis diameter more than PLA, with both fillers maintaining girth enhancement for up to 18 months. HA’s hydrophilic properties are the key differentiator for flaccid-state results. Belefil®, the specific HA-based filler used at Stoller Medical Group, is a medical-grade, biocompatible formulation designed for soft tissue augmentation.

Measuring What Matters: The Clinical Protocol Behind Accurate Outcome Assessment

Flaccid length alone is a poor predictor of erect length—stretched penile length (SPL) is the clinical gold standard used in research and practice. The standard pre- and post-procedure measurement protocol includes flaccid length, flaccid girth, stretched length, and erect length and girth to quantify gains in each state accurately.

The perception paradox is significant: the 2025 Peking University study found men systematically underestimate their own penile dimensions, especially in the flaccid state. Enhancement results may appear more dramatic to others than to the patient himself. Because men underestimate their flaccid size, even moderate flaccid gains can produce a significant psychological impact—which is why flaccid-state improvements are the primary driver of patient satisfaction.

Research demonstrates psychological durability: IMGI (genital image satisfaction) scores remained high even as HA filler effects diminished over 12 months, indicating that psychological benefit is more durable than the physical change alone. Accurate measurement forms a cornerstone of Stoller Medical Group’s consultation process—realistic goal-setting begins with precise baseline measurements and honest outcome projections for both flaccid and erect states.

What to Realistically Expect: Outcome Profiles by Enhancement Modality

Non-Surgical HA Filler (Belefil®): The Gold Standard for Girth in Both States

  • Flaccid girth: Mean increase of 2.5–3.41 cm depending on volume and timing; the dominant and most visible outcome
  • Erect girth: Mean increase of approximately 1.32 cm—smaller due to intracavernosal compression, but clinically significant and natural in appearance
  • Longevity: Results typically last 18–24 months; some protocols report longer retention
  • Recovery: Back on feet in 10 days; sexual activity resumes within 7–10 days
  • Satisfaction: 89% patient satisfaction in the 324-patient single-center study; over 15,000 procedures performed at Stoller Medical Group

Penile Traction Therapy: The Only Non-Surgical Method With Documented Erect Length Gains

  • Mean flaccid length increase: 1.7 cm; stretched length: 1.3 cm; erect length: 1.2 cm over 4–6 months
  • Works through mechanotransduction—sustained tension stimulates cellular proliferation
  • Does not significantly increase girth; best positioned as a length-focused complement
  • Requires significant patient compliance—a practical limitation for busy professionals

Surgical Options: Ligament Release and Grafting

Suspensory ligament release increases flaccid length by 1–3 cm on average by changing penile angle—it does not increase true erect length and can destabilize erection angle. The 2026 ICSM consensus mandates comprehensive patient counseling weighing pros and cons before any surgical treatment.

Stoller Medical Group’s decision not to offer surgical lengthening reflects a safety-first philosophy—the risk-benefit ratio for most patients favors non-surgical girth enhancement over surgical length procedures.

The Stoller Medical Group Approach: Personalized Planning for Both States

Stoller Medical Group’s consultation process incorporates the grower-shower framework: baseline measurements in flaccid, stretched, and erect states inform a personalized treatment plan that sets accurate expectations for both outcome states.

The staged treatment protocol allows providers to assess how each patient’s anatomy responds—particularly important for growers, where filler placement must account for erection-state expansion. Dr. Roy B. Stoller brings 25+ years in aesthetic medicine and five years dedicated specifically to non-surgical male enhancement, with 15,000+ procedures performed—clinical experience that enables accurate outcome prediction across anatomy types.

Belefil® is selected specifically because its hydrophilic, viscoelastic properties produce the most natural appearance in both flaccid and erect states—a material science decision, not a marketing choice. With five locations across Manhattan, Long Island, Albany, Pennsylvania, and Minnesota, plus complimentary consultations, the practice maintains accessibility while emphasizing complete discretion and confidentiality.

Setting Realistic Expectations: What Success Looks Like in Both States

Success in the flaccid state means a measurable, visible increase in girth that is immediately apparent—producing the confidence that 27% of men cite as their primary concern. Success in the erect state means a natural-feeling, proportional increase in girth that enhances intimate confidence without creating artificial texture or appearance.

The psychological dimension is meaningful: because men underestimate their own size, the psychological benefit of enhancement often exceeds what the patient perceives in the mirror. Satisfaction scores remain elevated even as physical gains attenuate over time.

Realistic expectations—set through honest, measurement-based consultation—are the foundation of high satisfaction rates. The 89% satisfaction figure from the 324-patient study reflects this approach.

Conclusion: Both States Matter—And So Does the Provider

Flaccid gains will always exceed erect gains across all enhancement modalities because intracavernosal pressure during erection compresses subcutaneous material. This is physiology, not a limitation of any specific procedure.

The grower-shower framework serves as a practical planning tool: knowing anatomy type allows skilled providers to customize staging, volume, and placement for optimal results in both states. HA filler—specifically Belefil®—produces the most natural results because its hydrophilic properties resist corpus contraction in the flaccid state, and its viscoelastic compressibility yields naturally to intracavernosal pressure during erection.

For high-income professional men who have never believed a credible solution existed, the combination of clinical evidence, experienced providers, and honest outcome planning has changed that calculus.

Schedule a Confidential Consultation

Stoller Medical Group offers complimentary, confidential consultations at any of five locations: Manhattan, Long Island, Albany, Pennsylvania, or Minnesota. The consultation includes baseline measurements in all three states, grower-shower assessment, personalized outcome projections, and a staged treatment plan—all before any commitment is made.

Complete discretion, a medical-first environment, and a provider with 15,000+ procedures of experience ensure this decision receives the seriousness it deserves. No surgical lengthening, staged conservative treatments, and hospital-grade protocols reflect the same standards high-income professionals expect from any elite medical provider.